Follow
Daniel Sop
Title
Cited by
Cited by
Year
Indirect economic burden of sickle cell disease
D Holdford, N Vendetti, DM Sop, S Johnson, WR Smith
Value in Health 24 (8), 1095-1101, 2021
282021
A randomised controlled provider‐blinded trial of community health workers in sickle cell anaemia: effects on haematologic variables and hydroxyurea adherence
WR Smith, DK McClish, R Lottenberg, IY Sisler, D Sop, S Johnson, ...
British Journal of Haematology 196 (1), 193-203, 2022
62022
Survey of physician perspective towards management of pain for chronic conditions in the emergency department
D Sop, W Smith, A Alsalman, JL Wong, DY Fei, D McClish, A Rafiq, ...
Modern clinical medicine research 1 (3), 55, 2017
52017
Feasibility and Quality Validation of a Mobile Application for Enhancing Adherence to Opioids in Sickle Cell Disease
DM Sop, T Crouch, Y Zhang, T Lipato, J Wilson, WR Smith
Healthcare 10 (8), 1506, 2022
22022
Using lean six sigma to develop a patient centered medical home for adults with sickle cell disease
S Johnson, S Hartigan, E Holt, D Sop, C McHenry, T Lipato, T Elliott, ...
Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019
22019
COVID symptoms and COVID anxiety in sickle cell disease
WR Smith, B Jaworowski, S Johnson, T Lipato, DM Sop
Blood 136, 16-17, 2020
12020
The effect of patient navigators on health-related quality of life in sickle cell anemia: the SHIP-HU study
WR Smith, D k McClish, S Johnson, R Lottenberg, D Sop, A Villella, ...
Blood 134, 2168, 2019
12019
Responsivity of Utilization Rates to the Intensity of Case Management over Time Among High-Utilizing Adults with Sickle Cell Disease
WR Smith, D Sop, S Johnson, T Lipato, S Hartigan
Blood 134, 5803, 2019
12019
The effect of patient navigators on laboratory parameters of hydroxyurea adherence in sickle cell anemia: the ship-hu study
WR Smith, D k McClish, R Lottenberg, D Sop, S Johnson, A Villella, ...
Blood 134, 2309, 2019
12019
The association of painful crises with patient reported outcomes in sickle cell disease: the SHIP-HU study
D k McClish, WR Smith, V Okhomiuna, DS Mouaffo, R Lottenberg, I Chen, ...
Blood 132, 3509, 2018
12018
Comparison of adult and adolescent quality of ambulatory and emergency care in sickle cell disease: ASCQ-Me and the SHIP-HU study
WR Smith, D k McClish, R Lottenberg, I Chen, MJ Treadwell, S Keller, ...
Blood 130, 2258, 2017
12017
Incidence, Prevalence, and Disease Management Impactability of High Utilization in an Adult Sickle Cell Medical Home
WR Smith, D Sop, YM Zhang, B Jaworowski, S Johnson
Blood 142, 7206, 2023
2023
Towards an Implicit Measure of Patient Engagement in Sickle Cell Disease: Relationships between Implicit Measures of Engagement and Previous Childhood Trauma Among Adolescents …
H Hartzog, S Johnson, R Walls, YM Zhang, D Sop, WR Smith
Blood 142, 7319, 2023
2023
Component-Specific Effects of Team Case Management on Adult Sickle Cell Utilization in Moderate to Low Utilizers
S Johnson, D Sop, A Hardy, R Walls, YM Zhang, B Jaworowski, WR Smith
Blood 142, 7197, 2023
2023
Relative Influence of Biological Versus Behavioral Determinants of Utilization Among Adults with Sickle Cell Disease
M Ferlis, D Sop, YM Zhang, WR Smith
Blood 142, 3680, 2023
2023
Association of Cerebral Hemodynamics and Anemia on Processing Speed in Adults with Sickle Cell Disease
WS Daniel Sop, Joel L Steinberg, Jennifer Jordan, Taylor Crouch, Yue May Zhang
Journal of Neurology and Experimental Neural Science 5 (01), 2023
2023
Intensive Case Management in an Adult Sickle Cell Medical Home: Annual Effects on Utilization Efficiency Using Community Health Workers
S Johnson, DM Sop, YM Zhang, B Jaworowski, WR Smith
Blood 140 (Supplement 1), 1625-1626, 2022
2022
Inpatient Reliance Ratio Versus Emergency Department Reliance Ratio in a Sickle Cell Disease Medical Home
DM Sop, YM Zhang, S Johnson, B Jaworowski, WR Smith
Blood 140 (Supplement 1), 7881-7882, 2022
2022
Sickle Cell Disease May Qualify As an Ambulatory Care Sensitive Condition
WR Smith, YM Zhang, S Johnson, DM Sop
Blood 140 (Supplement 1), 7862-7863, 2022
2022
Screening for Adverse Childhood Experiences (ACEs) As a Way to Predict Overdose Risk in Adult Sickle Cell Patients
R Walls, DM Sop, YM Zhang, B Jaworowski, S Johnson, WR Smith
Blood 140 (Supplement 1), 13039-13040, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–20